Skip to main content
MOA Life Plus Co. Ltd. logo

MOA Life Plus Co. Ltd. — Investor Relations & Filings

Ticker · 142760 ISIN · KR7142760008 KO Manufacturing
Open in API
Filings indexed 361 across all filing types
Latest filing 2023-09-21 Major Shareholding Noti…
Country KR South Korea
Listing KO 142760

About MOA Life Plus Co. Ltd.

http://moalifeplus.com/

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Recent filings

Filing Released Lang Actions
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from a Korean company (Biel) regarding a 'Correction Report' (정정신고) for a 'Pledge of Shares Agreement' (주식 담보제공 계약) involving the company's largest shareholder. This type of disclosure, which details changes in collateralized shares by a major shareholder, falls under the category of regulatory announcements regarding capital structure and share-related obligations. Since it does not fit into specific categories like 'Director's Dealing' (which usually refers to buying/selling) or 'Major Shareholding Notification' (which refers to threshold changes), it is best classified as a general Regulatory Filing (RNS).
2023-09-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and purpose of holding (management influence) by a major shareholder (Park Young Chul) of the company 'BL' (비엘). This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2023-09-21 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Pledge of Shares by the Largest Shareholder' (최대주주 변경을 수반하는 주식 담보제공 계약 체결). This type of filing details changes in collateralized shares and debt amounts, which falls under capital structure and financing updates. Since it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new equity), and it is a formal regulatory disclosure of a financial contract, it is classified as a Regulatory Filing (RNS).
2023-08-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and purpose of holding (management influence) by a major shareholder (Park Young Chul) of the company 'BioLeaders' (비엘). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-08-31 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of shares, and the underlying calculation methodology based on market price fluctuations. This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-08-18 Korean
기타경영사항(자율공시)(전환우선주 전환가액 조정)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible preferred shares due to a decline in market price. This type of corporate action, which affects the capital structure and potential share dilution, falls under the category of capital and financing updates. It is not a report publication announcement, but rather the primary disclosure of the financial event itself.
2023-08-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.